Drugs and biolgical
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00477
- Awardee
-
Discovery Labware Inc. UEI ZJFLZGNPSJK5 Part of Corning Incorporated
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,751
Award facts
- Contract value 100% obligated
- $24,751.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$70 | |
| Original award | $24,821 |
About this award
The National Cancer Institute awarded a purchase order to Discovery Labware Inc. for $24,751.02 on June 25, 2019 for drugs and biological products, with an ultimate completion date of March 31, 2024. The order was firm fixed price with no set-aside designation and is funded to de-obligate expiring FY2019 lines in accordance with NIH OALM communication. Work is performed in Bedford, Massachusetts.
Quick answers
Who was awarded contract 75N91019P00477?
75N91019P00477 was awarded to Discovery Labware Inc. by National Cancer Institute (National Institutes of Health) on June 25, 2019.
How much is contract 75N91019P00477 worth?
The government has obligated $24,751 on 75N91019P00477.
Was contract 75N91019P00477 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award